Alternations of ER, PR, HER-2/neu, and P53 protein expression in ductal breast carcinomas and clinical implications

By Liu Caigang   Zhang Hao   Shuang Chen   Lu Yang   Jin Feng   Xu Huimian   Lu Ping  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 747-752

Humana Press, Inc

Access to resources Recommend Favorite

The Expression of Epidermal Growth Factor Receptor, HER-2/ Neu, p53, and Ki-67 Antigen in Uterine Malignant Mixed Mesodermal Tumors and Adenosarcoma

By Swisher E.M.   Gown A.M.   Skelly M.   Ek M.   Tamimi H.K.   Cain J.M.   Greer B.E.   Muntz H.G.   Goff B.A.  

Gynecologic Oncology, Vol. 60, Iss. 1, 1996-01 ,pp. : 81-88

Academic Press

Access to resources Recommend Favorite

Semiautomated evaluation of Ki67 index in invasive ductal carcinoma of the breast

By            

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 107-114

Spandidos Publications

Access to resources Recommend Favorite

Correlation among 16 biological factors [p53, p21waf1, MIB1 (Ki67), p16INK4A, cyclin D1, Ecadherin, Bcl2, TNFα, NFκB, TGFβ, MMP7, COX2, EGFR, HER2/neu, ER, and HIF1α] and clinical outcomes following curative chemoradiation therapy in 10 patients with esophageal squamous cell carcinoma

By              

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 903-910

Spandidos Publications

Access to resources Recommend Favorite

p53 immunoreactivity correlates with Ki-67 and bcl-2 expression in renal cell carcinoma

By Olumi A.F.   Weidner N.   Presti J.C.  

Urologic Oncology: Seminars and Original Investigations, Vol. 6, Iss. 2, 2001-03 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite